Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 12,475 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 12,475 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider owned 259,057 shares of the company’s stock, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Up 14.8%

Shares of OSCR traded up $3.04 during midday trading on Thursday, hitting $23.54. 10,532,228 shares of the company’s stock traded hands, compared to its average volume of 7,845,401. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $25.58. The firm’s fifty day moving average is $17.92 and its 200-day moving average is $15.93. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a price-to-earnings-growth ratio of 1.48 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the prior year, the business posted $0.92 EPS. The business’s revenue for the quarter was up 52.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on OSCR shares. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a report on Thursday. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a report on Tuesday, April 21st. Wolfe Research started coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating for the company. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Finally, Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and increased their price objective for the company from $10.00 to $16.00 in a report on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of “Hold” and an average price target of $20.22.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE raised its stake in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after acquiring an additional 1,922,732 shares during the last quarter. Arkadios Wealth Advisors grew its position in Oscar Health by 9.4% during the 1st quarter. Arkadios Wealth Advisors now owns 14,275 shares of the company’s stock worth $164,000 after purchasing an additional 1,228 shares during the period. Amundi acquired a new stake in Oscar Health during the 1st quarter worth about $362,000. California State Teachers Retirement System grew its position in Oscar Health by 23.3% during the 1st quarter. California State Teachers Retirement System now owns 235,443 shares of the company’s stock worth $2,701,000 after purchasing an additional 44,443 shares during the period. Finally, Royal Bank of Canada grew its position in Oscar Health by 73.4% during the 1st quarter. Royal Bank of Canada now owns 282,904 shares of the company’s stock worth $3,246,000 after purchasing an additional 119,714 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.